John J. Barron, PharmD

Articles by John J. Barron, PharmD

Analyzing the Impact of Different Value-Based Insurance Design Programs

ByJohn J. Barron, PharmD,Qian Cai, MSc, MSPH,Ralph M. Turner, PhD,Jeff T. White, PharmD, MS,Laurie W. Amirpoor, PharmD

February 11th 2012

Total 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.

Latest Updated Articles

Analyzing the Impact of Different Value-Based Insurance Design Programs
Published: February 11th 2012 | Updated:

John J. Barron, PharmD

Articles by John J. Barron, PharmD

Analyzing the Impact of Different Value-Based Insurance Design Programs

Latest Updated Articles

Trending on Pharmacy Times

Understanding Second Primary Tumors in C-POST: Definitions, Incidence, and Clinical Implications of Cemiplimab

Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals

Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC